av/panbela-therapeutics--big.svg

COM:PANBELA

Panbela Therapeutics

  • Stock

USD

Last Close

0.35

22/11 20:00

Market Cap

1.71M

Beta: -

Volume Today

5.21K

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
average inventory
average payables
2.17K
-
292.67K
13,402.65%
915K
212.64%
1.22M
33.39%
1.13M
7.41%
830.50K
26.50%
575.50K
30.70%
597K
3.74%
1.75M
193.55%
6.40M
265.31%
average receivables
300.31K
-
479.96K
59.82%
527K
9.80%
370.50K
29.70%
376K
1.48%
346.50K
7.85%
342K
1.30%
322K
5.85%
185K
42.55%
24.50K
86.76%
book value per share
-1.76K
-
-2.29K
30.12%
-1.79K
21.62%
-1.24K
30.75%
68.98
105.56%
291.58
322.68%
1.31K
349.62%
1.05K
20.13%
-15.65
101.49%
-43.33K
276,823.74%
capex per share
-1.28
-
capex to depreciation
capex to operating cash flow
0.04
-
capex to revenue
0.40
-
cash per share
1.36K
-
789.25
42.17%
169.18
78.56%
51.16
69.76%
361.65
606.88%
515.58
42.56%
1.40K
171.55%
1.22K
13.09%
2.50
99.79%
23.72K
949,325.71%
days of inventory on hand
days payables outstanding
0.21
-
39.22
18,709.91%
87.93
124.19%
72.56
17.48%
99.81
37.55%
50.42
49.49%
35.14
30.30%
23.34
33.59%
30.67
31.44%
141.45
361.15%
days sales outstanding
61.04
-
-10.92
-
debt to assets
1.42
-
1.84
29.81%
3.74
103.18%
2.38
36.32%
0.18
92.25%
0.04
79.99%
1.37
-
0.08
93.84%
debt to equity
-2.73
-
-1.24
54.64%
-0.71
43.08%
-0.49
29.92%
1.31
363.98%
0.08
93.59%
-0.85
-
-0.21
75.03%
dividend yield
earnings yield
-3.72
-
-1.50
59.61%
-2.84
88.95%
-0.29
89.74%
-0.36
24.37%
-0.26
28.44%
-0.17
33.12%
-0.50
189.01%
-0.78
54.88%
-12.70K
1,638,161.62%
enterprise value
441.80K
-
5.68M
1,186.03%
4.64M
18.32%
37.33M
704.25%
15.26M
59.11%
21.61M
41.57%
18.51M
14.35%
8.38M
54.72%
50.62M
504.01%
-1.58M
103.11%
enterprise value over ebitda
-7.15
-
-1.05
85.38%
-0.90
14.05%
-6.21
590.74%
-3.51
43.39%
-4.89
39.14%
-3.59
26.46%
-0.79
78.03%
-1.46
84.40%
0.03
102.11%
ev to operating cash flow
-38.57
-
-1.46
96.22%
-1.94
32.74%
-10.97
466.90%
-6.39
41.72%
-7.89
23.38%
-4.80
39.13%
-1.25
73.97%
-3.31
165.08%
0.06
101.88%
ev to sales
0.33
-
-30.90
-
free cash flow per share
-95.44
-
-3.33K
3,383.89%
-926.23
72.14%
-1.15K
23.63%
-614.41
46.34%
-576.63
6.15%
-598.08
3.72%
-687.38
14.93%
-30.98
95.49%
-232.30K
749,701.08%
free cash flow yield
-0.40
-
-1.19
198.62%
-1.33
12.06%
-0.10
92.83%
-0.15
53.31%
-0.11
21.79%
-0.14
22.36%
-0.33
136.51%
-0.35
6.81%
-12.69K
3,589,111.74%
graham net net
-2.37K
-
-2.57K
8.63%
-1.87K
27.31%
-1.34K
28.18%
6.18
100.46%
202.26
3,174.13%
1.23K
506.06%
968.70
20.98%
-22.76
102.35%
-128.20K
563,247.43%
graham number
5.94K
-
14.71K
147.64%
8.92K
39.33%
9.88K
10.66%
1.54K
84.45%
2.93K
90.52%
4.67K
59.65%
4.95K
5.91%
154.63
96.87%
476.05K
307,754.29%
income quality
0.11
-
0.79
639.25%
0.47
40.69%
0.33
30.09%
0.40
23.27%
0.44
9.29%
0.81
82.97%
0.66
18.17%
0.44
33.89%
1.00
128.55%
intangibles to total assets
0
-
0
0
0
0
0
0
0
0
0
interest coverage
-2.12
-
-29.75
1,301.73%
-28.71
3.49%
-3.72
87.04%
-2.14
42.35%
-1.97
8.16%
-338.47
17,081.96%
-910
168.86%
-118.38
86.99%
161.81
236.69%
interest debt per share
5.10K
-
2.99K
41.34%
1.34K
55.39%
1.16K
13.24%
557.01
51.92%
486.32
12.69%
2.64
99.46%
1.13
57.25%
13.87
1,129.37%
6.28K
45,220.07%
inventory turnover
invested capital
-2.73
-
-1.24
54.64%
-0.71
43.08%
-0.49
29.92%
1.31
363.98%
0.08
93.59%
-0.85
-
-0.21
75.03%
market cap
28.80K
-
3.28M
11,294.44%
1.80M
45.09%
35.65M
1,878.53%
16.32M
54.23%
23.94M
46.72%
27.53M
14.99%
20.25M
26.45%
45.06M
122.54%
1.99K
100.00%
net current asset value
-227.00K
-
-2.76M
1,114.55%
-4.64M
68.37%
-3.69M
20.53%
217K
105.88%
1.33M
514.75%
8.39M
529.09%
9.62M
14.62%
-11.25M
216.96%
-13.45M
19.57%
net debt to ebitda
-6.68
-
-0.44
93.39%
-0.55
24.47%
-0.28
49.39%
0.24
187.30%
0.53
117.34%
1.75
232.04%
1.12
36.18%
-0.16
114.30%
0.03
119.24%
net income per share
-892.03
-
-4.20K
371.27%
-1.97K
53.03%
-3.49K
76.84%
-1.52K
56.47%
-1.31K
14.12%
-739.91
43.31%
-1.04K
40.44%
-67.91
93.46%
-232.43K
342,139.58%
operating cash flow per share
-95.44
-
-3.33K
3,383.89%
-926.23
72.14%
-1.15K
23.63%
-614.41
46.34%
-576.63
6.15%
-598.08
3.72%
-687.38
14.93%
-29.70
95.68%
-232.30K
782,096.26%
payables turnover
1.75K
-
9.31
99.47%
4.15
55.39%
5.03
21.18%
3.66
27.30%
7.24
97.97%
10.39
43.47%
15.64
50.59%
11.90
23.92%
2.58
78.32%
receivables turnover
5.98
-
-33.43
-
research and ddevelopement to revenue
-17.12
-
return on tangible assets
-0.26
-
-2.73
936.43%
-5.83
113.90%
-13.53
132.04%
-3.11
77.00%
-1.97
36.62%
-0.49
75.36%
-0.79
62.05%
-7.02
791.26%
-2.14
69.50%
revenue per share
11.31K
-
-3.18
-
roe
0.51
-
1.84
262.18%
1.10
40.08%
2.81
155.36%
-22.03
883.52%
-4.48
79.68%
-0.56
87.39%
-0.99
75.85%
4.34
537.30%
5.36
23.59%
roic
-0.20
-
-7.33
3,541.97%
3.55
148.43%
3.07
13.54%
-6.04
296.70%
-2.70
55.29%
-0.64
76.23%
-0.94
45.80%
28.20
3,115.36%
13.72
51.33%
sales general and administrative to revenue
0.62
-
-3.69
-
shareholders equity per share
-1.76K
-
-2.29K
30.12%
-1.79K
21.62%
-1.24K
30.75%
68.98
105.56%
291.58
322.68%
1.31K
349.62%
1.05K
20.13%
-15.65
101.49%
-43.33K
276,823.74%
stock based compensation to revenue
-0.66
-
tangible asset value
-210.96K
-
-2.68M
1,170.86%
-4.64M
73.14%
-3.69M
20.53%
268K
107.26%
1.39M
416.79%
8.45M
509.96%
10.21M
20.88%
-8.05M
178.82%
-4.71M
41.48%
tangible book value per share
-1.76K
-
-2.29K
30.12%
-1.79K
21.62%
-1.24K
30.75%
68.98
105.56%
291.58
322.68%
1.31K
349.62%
1.05K
20.13%
-15.65
101.49%
-43.33K
276,823.74%
working capital
-224.59K
-
357K
258.96%
-4.64M
1,400.28%
-3.40M
26.69%
217K
106.38%
1.33M
514.75%
8.39M
529.09%
9.62M
14.62%
-6.06M
162.96%
-9.26M
52.87%

All numbers in USD (except ratios and percentages)